• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    T. Rowe Price Health Sciences (PRHSX)

    69.74 Up 0.47(0.68%) Dec 19
    Prev Close:69.27
    YTD Return*:30.88%
    Net Assets*:11.57B
    Yield*:N/A

    * As of 30-Nov-14

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Top Holdings

    Symbol% AssetsYTD Return %
    GILD5.5736.07
    ALXN4.6051.10
    MCK3.3031.15
    BIIB3.2617.42
    ACT3.1457.27

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:11.57B
    Category:Health
    Annual Report Expense Ratio (net):0.79%

    Performance & Risk

    YTD Return:30.88%
    5y Avg Return:28.72%
    Rank in Category (ytd):24
    % Rank in Category (ytd):19.05%
    Beta (3y):0.81
    Morningstar Risk Rating:4

    Fund Summary

    The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While it can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. The fund may invest in foreign stocks and options in keeping with the fund's objectives. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback